Author | Mary Caffrey


New Renal, HF Results Seen in 2020 ACC Pathway on CV Risk Reduction

August 05, 2020


The American College of Cardiology updates guidance on prescribing SGLT2 inhibitors and GLP-1 receptor agonists to patients with type 2 diabetes and cardiovascular disease or CV risk.

Hospitals Vow to Fight Court of Appeals 340B Ruling

August 03, 2020


The ruling reversed a lower court ruling regarding the drug discount program for hospitals that serve patients covered by Medicaid.

Tafasitamab Combination Approved for Adults With R/R DLBCL

August 02, 2020


A new treatment option is approved for patients with a common form of non-Hodgkin lymphoma who cannot have an autologous stem cell transplant.

Osimertinib Granted Breakthrough Status for Early-Stage, EGFR-Mutated NSCLC Patients After Surgery

July 31, 2020


The ADAURA trial was stopped in April 2020 after an independent monitoring committee called for the trial to be unblinded 2 years early based on a determination of overwhelming efficacy.